1. Home
  2. SCPH vs FXNC Comparison

SCPH vs FXNC Comparison

Compare SCPH & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • FXNC
  • Stock Information
  • Founded
  • SCPH 2013
  • FXNC 1907
  • Country
  • SCPH United States
  • FXNC United States
  • Employees
  • SCPH N/A
  • FXNC N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • FXNC Major Banks
  • Sector
  • SCPH Health Care
  • FXNC Finance
  • Exchange
  • SCPH Nasdaq
  • FXNC Nasdaq
  • Market Cap
  • SCPH 173.6M
  • FXNC 201.9M
  • IPO Year
  • SCPH 2017
  • FXNC N/A
  • Fundamental
  • Price
  • SCPH $2.78
  • FXNC $22.55
  • Analyst Decision
  • SCPH Strong Buy
  • FXNC Strong Buy
  • Analyst Count
  • SCPH 3
  • FXNC 1
  • Target Price
  • SCPH $14.00
  • FXNC $21.00
  • AVG Volume (30 Days)
  • SCPH 629.3K
  • FXNC 30.6K
  • Earning Date
  • SCPH 03-19-2025
  • FXNC 04-29-2025
  • Dividend Yield
  • SCPH N/A
  • FXNC 2.74%
  • EPS Growth
  • SCPH N/A
  • FXNC N/A
  • EPS
  • SCPH N/A
  • FXNC 1.00
  • Revenue
  • SCPH $36,332,000.00
  • FXNC $58,015,000.00
  • Revenue This Year
  • SCPH $134.20
  • FXNC $57.53
  • Revenue Next Year
  • SCPH $99.40
  • FXNC $4.24
  • P/E Ratio
  • SCPH N/A
  • FXNC $22.65
  • Revenue Growth
  • SCPH 167.28
  • FXNC 18.29
  • 52 Week Low
  • SCPH $2.72
  • FXNC $14.50
  • 52 Week High
  • SCPH $5.65
  • FXNC $26.97
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 34.45
  • FXNC 39.24
  • Support Level
  • SCPH $2.87
  • FXNC $22.05
  • Resistance Level
  • SCPH $3.08
  • FXNC $24.05
  • Average True Range (ATR)
  • SCPH 0.18
  • FXNC 0.60
  • MACD
  • SCPH -0.00
  • FXNC 0.11
  • Stochastic Oscillator
  • SCPH 11.70
  • FXNC 39.02

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.

Share on Social Networks: